Clinical Trial Update: AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients [EARLY_Phase 1]

View source ↗

Summary

AZD1390 is being studied in an early-phase trial for recurrent and newly diagnosed WHO grade 4 gliomas (glioblastoma/high-grade glioma), with the study status l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• AZD1390

Snippet

Sponsor: Nader Sanai | Conditions: Glioblastoma, Glioma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING